Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
08 Maggio 2024 - 3:00PM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) today announced that Joshua Cohen and Justin Klee,
Co-CEOs of Amylyx, and Camille L. Bedrosian, MD, Chief Medical
Officer of Amylyx, will participate in the 2024 Bank of America
Health Care Conference. The conference is being conducted in-person
in Las Vegas, Nevada, and the fireside chat will take place on
Wednesday, May 15, 2024, at 8:40 a.m. PT/11:40 a.m. ET.
A live webcast of the presentation can be accessed under
“Events” in the Investor section of the Company’s website,
https://investors.amylyx.com/news-events/events, and will be
available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative disease community
through the discovery and development of innovative new treatments.
Amylyx is headquartered in Cambridge, Massachusetts. For more
information, visit amylyx.com and follow us on LinkedIn and X,
formerly known as Twitter. For investors, please visit
investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508136396/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1 (857)
320-6244 Investors@amylyx.com
Grafico Azioni Amylyx Pharmaceuticals (NASDAQ:AMLX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Amylyx Pharmaceuticals (NASDAQ:AMLX)
Storico
Da Giu 2023 a Giu 2024
